Related Experiment Video
Updated: Sep 8, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Divergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in
Noshad Hosseini1,2, Rahul Mannan2,3, Ryan J Rebernick1,2
1Gilbert S. Omenn Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan.
Lethal prostate cancer (PCa) evolves independently across metastatic sites, with most genetic changes occurring after spread. This highlights the need for multi-site analysis in cancer diagnostics and therapy.
Area of Science:
- Genomics
- Evolutionary Biology
- Oncology
Background:
- Lethal prostate cancer (PCa) undergoes evolutionary bottlenecks, including metastasis and castration resistance.
- Understanding genetic heterogeneity across metastatic sites is crucial for developing effective treatment strategies.
Purpose of the Study:
- To investigate patterns of metastatic dissemination and clonal evolution in lethal prostate cancer.
- To characterize the genetic landscape of PCa across multiple metastatic sites within individual patients.
Main Methods:
- Deep whole-exome sequencing of 93 tumors from 26 patients.
- Phylogenetic reconstruction and mathematical modeling to analyze clonal evolution and mutation patterns.
Main Results:
- Most mutations, copy-number alterations, and clones arose independently within individual metastatic sites after initial cancer spread.
- Polyclonal and polyphyletic seeding contributed to the heterogeneity of metastatic lesions.
- Single-tissue sequencing can overestimate clonality and underestimate mutation rates.
Conclusions:
- Metastatic lesions in prostate cancer evolve independently, driven by polyclonal seeding.
- These findings have significant implications for the interpretation of diagnostic data and the development of targeted therapies.
- Multi-site tumor sequencing is essential for a comprehensive understanding of PCa evolution and for guiding treatment decisions.
More Related Videos
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

